New York State Teachers Retirement System Has $66.81 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

New York State Teachers Retirement System decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 207,963 shares of the company’s stock after selling 5,240 shares during the quarter. New York State Teachers Retirement System owned approximately 0.08% of HCA Healthcare worth $66,814,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Parkside Financial Bank & Trust lifted its position in shares of HCA Healthcare by 8.2% during the fourth quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock worth $125,000 after purchasing an additional 35 shares in the last quarter. FinTrust Capital Advisors LLC boosted its position in HCA Healthcare by 26.7% in the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after buying an additional 35 shares during the last quarter. Financial Counselors Inc. lifted its stake in shares of HCA Healthcare by 1.4% during the first quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock valued at $881,000 after acquiring an additional 36 shares during the period. Westside Investment Management Inc. increased its position in HCA Healthcare by 14.7% in the second quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock worth $93,000 after purchasing an additional 37 shares during the period. Finally, ZWJ Investment Counsel Inc. boosted its stake in shares of HCA Healthcare by 3.5% in the 2nd quarter. ZWJ Investment Counsel Inc. now owns 1,082 shares of the company’s stock valued at $348,000 after purchasing an additional 37 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on HCA shares. UBS Group raised their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Royal Bank of Canada increased their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Finally, SVB Leerink raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Four investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $356.17.

HCA Healthcare Stock Up 1.2 %

NYSE:HCA traded up $4.47 on Friday, hitting $387.59. 376,598 shares of the company’s stock were exchanged, compared to its average volume of 1,133,380. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $388.21. The company has a market cap of $101.52 billion, a P/E ratio of 19.21, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The firm has a 50-day moving average price of $343.45 and a 200-day moving average price of $330.36.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.29 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.68%. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Insider Buying and Selling

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,844 shares of company stock valued at $3,185,932. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.